Effect of Combination Treatment with GLP-1 Receptor Agonist and SGLT-2 Inhibitors on Incidence of Cardiovascular and Serious Renal Events . (2024). Medical Forum Monthly, 35(6). https://medicalforummonthly.com/index.php/mfm/article/view/4697